SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-146562
Filing Date
2018-05-01
Accepted
2018-05-01 16:06:04
Documents
6
Period of Report
2018-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d557823d6k.htm 6-K 10473
2 EX-99.1 d557823dex991.htm EX-99.1 25068
3 EX-99.2 d557823dex992.htm EX-99.2 708798
4 GRAPHIC g557823dsp11.jpg GRAPHIC 27134
5 GRAPHIC g557823g0501014801681.jpg GRAPHIC 2362
6 GRAPHIC g557823g95g47.jpg GRAPHIC 5325
  Complete submission text file 0001193125-18-146562.txt   793693
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 18795519
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1